Therapeutic Area: Oncology - Head and Neck Cancer
Phase: Phase III for EMEA submission
Study Type/ Design: Randomized, double blind
Status: Completed and Approved
Type of Client: European multinational pharmaceutical company
Click here to view the details
Therapeutic Area: Urology - Overactive Bladder
Phase: Phase II, POC, First in Patients study
Study Type/ Design: Randomized
Status: Completed
Type of Client: European multinational pharmaceutical company
Click here to view the details
Therapeutic Area: Infectious diseases - Hepatitis B
Phase: Phase II
Study Type/ Design: Complex protocol, study shutdown due to in adequate patient numbers in US.
Status: Completed
Type of Client: North American pharmaceutical company
Click here to view the details
Therapeutic Area: Ophthalmology
Phase: Phase III for USFDA submission
Study Type/ Design: Randomized, Complex protocol, more than 40% of patients from India.
Status: Completed, drug being marketed
Type of Client: US multinational pharmaceutical company
Click here to view the details
Therapeutic Area: Immunology/ Oncology
Phase: Phase II
Study Type/ Design: Single arm, Open label, multicentric study
Status: Ongoing
Type of Client: US pharmaceutical Company
Click here to view the details
Therapeutic Area: Renal Transplantation
Phase: Phase IV
Study Type/ Design: Single arm, Open label, Multicentric study
Status: Completed
Type of Client: Indian pharmaceutical company
Click here to view the details
Therapeutic Area: Oncology - Multiple Myeloma
Phase: Phase I
Study Type/ Design: Open label, Multicentric, Dose escalation study
Status: Completed, patients in follow up phase
Type of Client: US multinational pharmaceutical company
Click here to view the details
Therapeutic Area: Oncology - Glioma
Phase: Phase II
Study Type/ Design: Open-Label, Dose Confirmation Study.
Status: Ongoing
Type of Client: US pharmaceutical company
Click here to view the details
Therapeutic Area: Diabetes
Phase: Phase III
Study Type/ Design: Multicentric randomized double blind, placebo controlled
Status: Complete
Type of Client: Indian biotech company
Click here to view the details
Therapeutic Area: Diabetes
Phase: Phase II
Study Type/ Design: Proof of Concept study
Status: Study terminated prematurely
Type of Client: Indian pharmaceutical company
Click here to view the details
|
